Transaction · 0001933414-26-000121

Congleton Jon

Congleton Jon, CEO, reported an open-market or private sale at Mineralys Therapeutics, Inc. involving 75000.000000 shares for an estimated $1909665.00. Reported holdings after the transaction were 528621.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO
MLYSMineralys Therapeutics, Inc.
Filing timeOct 02
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded12.43%Shares sold ÷ (holdings after + shares sold). Estimated position before: 603,621 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$23.63
Pre-filing
1mo ago +11.6%1w ago +13.8%1d ago +3.6%
Returns since
7d30d90d180d1y

MLYS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MLYS since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001933414-26-000121
Common Stock
Transaction date
Sep 30, 2026
Filed Oct 02, 2026, 09:53 PM · 2d delay
Shares
75.0k sh
$25.46 per share
Estimated value
-$1.90M
Computed from shares × price
Holdings after
528k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025.

  2. F2

    The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.8201. The Reporting Person undertakes to provide to t…

Original filing · 0001933414-26-000121
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MLYS